Tracking Cardiac Rehabilitation Participation and Completion Among Medicare Beneficiaries to Inform the Efforts of a National Initiative.
Age Factors
Aged
Aged, 80 and over
Cardiac Rehabilitation
/ trends
Databases, Factual
Eligibility Determination
/ trends
Female
Healthcare Disparities
/ trends
Heart Diseases
/ diagnosis
Humans
Insurance Benefits
/ trends
Male
Medicare
/ trends
Middle Aged
Outcome and Process Assessment, Health Care
/ trends
Patient Compliance
Patient Participation
/ trends
Prevalence
Sex Factors
Time Factors
Treatment Outcome
United States
/ epidemiology
cardiac rehabilitation
coronary artery bypass
heart diseases
myocardial infarction
percutaneous coronary intervention
Journal
Circulation. Cardiovascular quality and outcomes
ISSN: 1941-7705
Titre abrégé: Circ Cardiovasc Qual Outcomes
Pays: United States
ID NLM: 101489148
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
entrez:
15
1
2020
pubmed:
15
1
2020
medline:
28
8
2020
Statut:
ppublish
Résumé
Despite cardiac rehabilitation (CR) being shown to improve health outcomes among patients with heart disease, its use has been suboptimal. In response, the Million Hearts Cardiac Rehabilitation Collaborative developed a road map to improve CR use, including increasing participation rates to ≥70% by 2022. This observational study provides current estimates to measure progress and identifies the populations and regions most at risk for CR service underutilization. We identified Medicare fee-for-service beneficiaries who were CR eligible in 2016, and assessed CR participation (≥1 CR session attended), timely initiation (participation within 21 days of event), and completion (≥36 sessions attended) through 2017. Measures were assessed overall, by beneficiary characteristics and geography, and by primary CR-qualifying event type (acute myocardial infarction hospitalization; coronary artery bypass surgery; heart valve repair/replacement; percutaneous coronary intervention; or heart/heart-lung transplant). Among 366 103 CR-eligible beneficiaries, 89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days and 26.9% completed CR. Eligibility was highest in the East South Central Census Division (14.8 per 1000). Participation decreased with increasing age, was lower among women (18.9%) compared with men (28.6%; adjusted prevalence ratio: 0.91 [95% CI, 0.90-0.93]) was lower among Hispanics (13.2%) and non-Hispanic blacks (13.6%) compared with non-Hispanic whites (25.8%; adjusted prevalence ratio: 0.63 [0.61-0.66] and 0.70 [0.67-0.72], respectively), and varied by hospital referral region and Census Division (range: 18.6% [East South Central] to 39.1% [West North Central]) and by qualifying event type (range: 7.1% [acute myocardial infarction without procedure] to 55.3% [coronary artery bypass surgery only]). Timely initiation varied by geography and qualifying event type; completion varied by geography. Only 1 in 4 CR-eligible Medicare beneficiaries participated in CR and marked disparities were observed. Reinforcement of current effective strategies and development of new strategies will be critical to address the noted disparities and achieve the 70% participation goal.
Sections du résumé
BACKGROUND
Despite cardiac rehabilitation (CR) being shown to improve health outcomes among patients with heart disease, its use has been suboptimal. In response, the Million Hearts Cardiac Rehabilitation Collaborative developed a road map to improve CR use, including increasing participation rates to ≥70% by 2022. This observational study provides current estimates to measure progress and identifies the populations and regions most at risk for CR service underutilization.
METHODS AND RESULTS
We identified Medicare fee-for-service beneficiaries who were CR eligible in 2016, and assessed CR participation (≥1 CR session attended), timely initiation (participation within 21 days of event), and completion (≥36 sessions attended) through 2017. Measures were assessed overall, by beneficiary characteristics and geography, and by primary CR-qualifying event type (acute myocardial infarction hospitalization; coronary artery bypass surgery; heart valve repair/replacement; percutaneous coronary intervention; or heart/heart-lung transplant). Among 366 103 CR-eligible beneficiaries, 89 327 (24.4%) participated in CR, of whom 24.3% initiated within 21 days and 26.9% completed CR. Eligibility was highest in the East South Central Census Division (14.8 per 1000). Participation decreased with increasing age, was lower among women (18.9%) compared with men (28.6%; adjusted prevalence ratio: 0.91 [95% CI, 0.90-0.93]) was lower among Hispanics (13.2%) and non-Hispanic blacks (13.6%) compared with non-Hispanic whites (25.8%; adjusted prevalence ratio: 0.63 [0.61-0.66] and 0.70 [0.67-0.72], respectively), and varied by hospital referral region and Census Division (range: 18.6% [East South Central] to 39.1% [West North Central]) and by qualifying event type (range: 7.1% [acute myocardial infarction without procedure] to 55.3% [coronary artery bypass surgery only]). Timely initiation varied by geography and qualifying event type; completion varied by geography.
CONCLUSIONS
Only 1 in 4 CR-eligible Medicare beneficiaries participated in CR and marked disparities were observed. Reinforcement of current effective strategies and development of new strategies will be critical to address the noted disparities and achieve the 70% participation goal.
Identifiants
pubmed: 31931615
doi: 10.1161/CIRCOUTCOMES.119.005902
pmc: PMC8091573
mid: NIHMS1693997
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e005902Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Références
J Cardiopulm Rehabil Prev. 2017 Sep;37(5):322-328
pubmed: 28858032
N Engl J Med. 2001 Sep 20;345(12):892-902
pubmed: 11565523
Circulation. 2010 Jan 5;121(1):63-70
pubmed: 20026778
J Gen Intern Med. 2014 Mar;29(3):529-37
pubmed: 24081443
J Am Coll Cardiol. 2011 Nov 29;58(23):2432-46
pubmed: 22055990
Cochrane Database Syst Rev. 2016 Jan 05;(1):CD001800
pubmed: 26730878
N Engl J Med. 2011 Sep 29;365(13):e27
pubmed: 21913835
Int J Cardiol. 2016 Nov 15;223:436-443
pubmed: 27557484
J Am Heart Assoc. 2017 Oct 11;6(10):
pubmed: 29021267
J Am Coll Cardiol. 2009 Jun 30;54(1):25-33
pubmed: 19555836
J Cardiopulm Rehabil Prev. 2015 May-Jun;35(3):173-80
pubmed: 25763922
J Am Heart Assoc. 2017 May 2;6(5):
pubmed: 28465301
J Cardiopulm Rehabil Prev. 2011 Jul-Aug;31(4):203-10
pubmed: 21705915
J Am Soc Nephrol. 2013 Sep;24(9):1478-83
pubmed: 23907508
Ann Epidemiol. 2017 Dec;27(12):796-800
pubmed: 29122432
Arch Intern Med. 2011 Feb 14;171(3):235-41
pubmed: 21325114
Circ J. 2014;78(2):377-84
pubmed: 24225305
Prev Cardiol. 2006 Winter;9(1):8-13
pubmed: 16407697
Cochrane Database Syst Rev. 2014 Apr 27;(4):CD003331
pubmed: 24771460
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):869-873
pubmed: 28837549
Circulation. 2018 May 1;137(18):1899-1908
pubmed: 29305529
Circulation. 2007 Oct 9;116(15):1653-62
pubmed: 17893274
Stat Med. 2016 Dec 30;35(30):5730-5735
pubmed: 27460748
Heart. 2016 Aug 1;102(15):1183-92
pubmed: 26936337
Mayo Clin Proc. 2017 Feb;92(2):234-242
pubmed: 27855953
Int J Cardiol Heart Vasc. 2015 Apr 08;7:170-175
pubmed: 28785669
J Cardiopulm Rehabil Prev. 2014 Sep-Oct;34(5):318-26
pubmed: 25098437
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e000037
pubmed: 29599285
Circulation. 2013 Jan 22;127(3):349-55
pubmed: 23250992
Mayo Clin Proc. 2017 Mar 13;:
pubmed: 28365100
J Cardiopulm Rehabil Prev. 2017 Mar;37(2):103-110
pubmed: 28033166
PM R. 2014 Jun;6(6):486-92
pubmed: 24321413
Circulation. 2012 Aug 7;126(6):677-87
pubmed: 22777176
J Card Fail. 2017 May;23(5):427-431
pubmed: 28232047
Cochrane Database Syst Rev. 2017 Jun 30;6:CD007130
pubmed: 28665511
N Engl J Med. 2004 Sep 23;351(13):1285-95
pubmed: 15385655
Cochrane Database Syst Rev. 2016 Mar 21;3:CD010876
pubmed: 26998683
J Cardiopulm Rehabil Prev. 2015 Nov-Dec;35(6):390-8
pubmed: 26468632
J Cardiopulm Rehabil Prev. 2008 Nov-Dec;28(6):380-5
pubmed: 19008692